The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa

被引：0
|
作者：
Hanagasi, HA [1 ]
Kaptanoglu, G [1 ]
Sahin, HA [1 ]
Emre, M [1 ]
机构：
[1] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Behav Neurol & Movement Disorders Unit, TR-34390 Istanbul, Turkey
来源：
MOVEMENT DISORDERS | 2000年 / 15卷 / 05期
关键词：
D O I：
10.1002/1531-8257(200009)15:5<1016::AID-MDS1042>3.0.CO;2-J
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1016 / 1017
页数：2
相关论文
共 48 条
  • [41] Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study
    Colman, Rebecca E.
    Anderson, Julia
    Lemmer, Darrin
    Lehmkuhl, Erik
    Georghiou, Sophia B.
    Heaton, Hannah
    Wiggins, Kristin
    Gillece, John D.
    Schupp, James M.
    Catanzaro, Donald G.
    Crudu, Valeriu
    Cohen, Ted
    Rodwell, Timothy C.
    Engelthaler, David M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (08) : 2058 - 2067
  • [42] 12-week, double-blind, placebo-controlled, fixed-dose study of immediate release AFQ056, an mGluR5 receptor antagonist, in Parkinson's disease patients with moderate-to-severe L-dopa induced dyskinesias
    Stocchi, F.
    Balaguer, E.
    Trenkwalder, C.
    Shah, A.
    Dronamraju, N.
    Tran, M.
    Kenney, C.
    Graf, A.
    MOVEMENT DISORDERS, 2014, 29 : S268 - S268
  • [43] 13-week, double-blind, placebo-controlled, fixed-dose study of modified release AFQ056, an mGluR5 receptor antagonist, in Parkinson's disease patients with moderate-to-severe L-dopa induced dyskinesias
    Trenkwalder, C.
    Kulisevsky, J.
    Poewe, W.
    Shah, A.
    Han, G.
    Tran, M.
    Kenney, C.
    Graf, A.
    MOVEMENT DISORDERS, 2014, 29 : S271 - S272
  • [44] Quality of life and cannabis use among patients with drug-resistant epilepsy-An observational study from a Canadian tertiary care referral center
    Jhanji, Kanika
    Shivji, Zaitoon
    Lazaj, Marion
    Lomax, Lysa Boisse
    Winston, Gavin P.
    Shukla, Garima
    EPILEPTIC DISORDERS, 2024, 26 (06) : 779 - 786
  • [45] Combined use of the adenosine A2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
    Kanda, T
    Jackson, MJ
    Smith, LA
    Pearce, RKB
    Nakamura, J
    Kase, H
    Kuwana, Y
    Jenner, P
    EXPERIMENTAL NEUROLOGY, 2000, 162 (02) : 321 - 327
  • [46] USE OF TSK-SW COLUMNS FOR THE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF PROTEINS, ISOLATED FROM SYMPATHETIC-NERVES AND FRACTIONATED BY FRACTOGEL TSK-HW CHROMATOGRAPHY - PURIFICATION OF L-DOPA DECARBOXYLASE
    HUSSEINI, HS
    BALZER, HO
    JOURNAL OF CHROMATOGRAPHY, 1984, 297 (AUG): : 375 - 383
  • [47] A laboratory method for the single-passage selection of drug-resistant mutants from populations of Eimeria species in chickens and its potential value in the choice of field use concentrations for new anticoccidial drugs
    Williams, RB
    AVIAN PATHOLOGY, 1998, 27 (04) : 366 - 372
  • [48] Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses
    Musharrafieh, Rami
    Ma, Chunlong
    Wang, Jun
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 141
12345